Evidence map›Paper›PMID 42047860›Full record

ArticleEuropean journal of pediatrics2026

Predictive value of quantitative NS1 antigen, IgM and IgG antibody titres in assessing dengue severity in children.

Padma Priya K H, Preetha Gerin, Vasanthi Thiruvengadam

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Padma Priya K HKanchi Kamakoti CHILDS Trust Hospital, Chennai, India. khpadmapriya@gmail.com.
Preetha GerinKanchi Kamakoti CHILDS Trust Hospital, Chennai, India.
Vasanthi ThiruvengadamDepartment of Paediatrics, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objectives of the study are to evaluate whether quantitative NS1 antigen and IgM/IgG antibody titres predict clinical severity in paediatric dengue and to determine whether the IgM/IgG ratio reliably differentiates primary from secondary infection. A 1-year cross-sectional study was conducted at a tertiary care centre in South India, enrolling children aged 1 month to 18 years with laboratory-confirmed dengue. Quantitative NS1 antigen, IgM, and IgG titres were measured at point-of-care and correlated with clinical outcomes. Severity indices included bleeding manifestations, third spacing, thrombocytopenia, hepatic and renal involvement, shock, and duration of hospitalization. Statistical analysis was performed using chi-square and Mann-Whitney U tests, with receiver operating characteristic (ROC) and area under the ROC curve (AUROC) analyses using IBM SPSS version 29. High NS1 titres (60-100 and ≥ 100) were significantly associated with bleeding, renal dysfunction, elevated SGOT, haemoconcentration, and thrombocytopenia. IgM titres < 4 correlated strongly with third spacing (82.1%, p = 0.019), while IgG titres ≥ 35 predicted third spacing (75%), thrombocytopenia, and elevated transaminases. An IgM/IgG ratio < 0.85 differentiated secondary dengue with superior sensitivity and specificity compared with higher cutoffs (AUROC 0.793). Infantile dengue demonstrated greater severity, with hypoalbuminemia (62%) and central nervous system involvement (25%), despite lower NS1 detection rates, and showed reversal of the typical SGOT > SGPT pattern.

conclusionQuantitative NS1 antigen and IgM/IgG antibody titres provide early severity-predictive information in paediatric dengue. An IgM/IgG ratio < 0.85 reliably identifies secondary infection. Incorporating these markers into routine clinical evaluation may enhance early risk stratification, particularly in resource-limited settings. WHAT IS KNOWN: • NS1 antigen and IgM/IgG antibody titters are widely used for diagnosis, and IgM/IgG ratio is commonly used to classify primary versus secondary dengue. • Dengue severity is higher in secondary infection and is usually assessed using haemoconcentration, thrombocytopenia, and clinical warning signs which often appear late. WHAT IS NEW: • Quantitative titters-High NS1 and low IgM antibody titres predict paediatric dengue severity early, allowing identification of high-risk children at presentation. • Infants show lower NS1 titters but higher severity; IgG titres in secondary dengue do not correlate with day of illness; an IgM/IgG ratio < 0.85 outperforms higher cutoffs (1.59) in identifying secondary dengue.

Indexed as

Antibodies, ViralAntigens, ViralDengueDengue VirusImmunoglobulin GImmunoglobulin MViral Nonstructural ProteinsAdolescentBiomarkersChildChild, PreschoolCross-Sectional StudiesFemaleHumansIndiaInfantAntibodies, ViralAntigens, ViralBiomarkersImmunoglobulin GImmunoglobulin MViral Nonstructural ProteinsIgM/IgG ratioNS1Primary dengueSecondary dengueSevere dengue

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.